VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,465,000 | -44.4% | 245,808 | +115.0% | 0.50% | -22.5% |
| Q4 2015 | $11,619,000 | -69.9% | 114,303 | -57.6% | 0.65% | -55.8% |
| Q4 2014 | $38,540,000 | -37.2% | 269,300 | -42.4% | 1.47% | -35.0% |
| Q3 2014 | $61,390,000 | +13.8% | 467,912 | +9.3% | 2.26% | +39.1% |
| Q2 2014 | $53,968,000 | +91.6% | 427,912 | +58.5% | 1.63% | +21.1% |
| Q3 2013 | $28,169,000 | +36.4% | 270,000 | +12.5% | 1.34% | +1.6% |
| Q2 2013 | $20,659,000 | – | 240,000 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |